Tanox Pharma B.V.
Records under this name other than patents Tanox Pharma B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Tanox Pharma B.V.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,479,552 | Type-1 ribosome-inactivating protein Formerly held Term ended Term ended Mar 23, 2020 · From the USPTO record | Term ended | Term ended Mar 23, 2020 | From the USPTO record |
| US 6,680,296 | Type-1 ribosome-inactivating protein Formerly held Term ended Term ended Mar 10, 2020 · From the USPTO record | Term ended | Term ended Mar 10, 2020 | From the USPTO record |
| US 6,645,494 | Anti-CD40L immunotoxins for the treatment of diseases Formerly held Lapsed on the fee record Ended Nov 11, 2011 · From the USPTO record | Lapsed on the fee record | Ended Nov 11, 2011 | From the USPTO record |